Revolutions Medical CORP: 10-K filed 2012-03-30
What Revolutions Medical CORP reported in its annual report filed 2012-03-30 (fiscal FY 2011): 25 published measures, 75 facts as tagged in accession 0001144204-12-018960.
This filing
- Form
- 10-K (annual report)
- Filed
- 2012-03-30
- Fiscal period
- fiscal FY 2011
- Accession
- 0001144204-12-018960 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Revolutions Medical CORP filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 1,978,711 | USD | |
| At 2010-12-31 | 1,234,029 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 2,294,274 | USD | |
| At 2010-12-31 | 1,581,109 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | -315,563 | USD | |
| At 2010-12-31 | -347,080 | USD | |
| At 2009-12-31 | -448,786 | USD | |
| At 2008-12-31 | -1,740,143 | USD | |
| At 2007-12-31 | -1,645,612 | USD | |
| At 2006-12-31 | -1,427,270 | USD | |
| At 2005-12-31 | -480,902 | USD | |
| At 2004-12-31 | -1,108,531 | USD | |
| At 2003-12-31 | -820,473 | USD | |
| At 2002-12-31 | -147,815 | USD | |
| At 2001-12-31 | 236,263 | USD | |
| At 2000-12-31 | 47,327 | USD | |
| At 1999-12-31 | 739,798 | USD | |
| At 1998-12-31 | 742,201 | USD | |
| At 1997-12-31 | 890,808 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 4,844 | USD | |
| At 2010-12-31 | 69,517 | USD | |
| At 2009-12-31 | 67,228 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -4,218,278 | USD | 365 |
| 1996-08-16 to 2011-12-31 | -29,834,791 | USD | 5616 |
| 2010-01-01 to 2010-12-31 | -2,615,046 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -3,010,275 | USD | 365 |
| 1996-08-16 to 2011-12-31 | -11,118,787 | USD | 5616 |
| 2010-01-01 to 2010-12-31 | -1,208,525 | USD | 365 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 340,321 | USD | 365 |
| 1996-08-16 to 2011-12-31 | 1,229,423 | USD | 5616 |
| 2010-01-01 to 2010-12-31 | 782,375 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 3,416,949 | USD | 365 |
| 1996-08-16 to 2011-12-31 | 12,978,644 | USD | 5616 |
| 2010-01-01 to 2010-12-31 | 1,993,189 | USD | 365 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -471,347 | USD | 365 |
| 1996-08-16 to 2011-12-31 | -1,657,446 | USD | 5616 |
| 2010-01-01 to 2010-12-31 | -782,375 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | -29,834,791 | USD | |
| At 2010-12-31 | -25,616,512 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 1,185,664 | USD | |
| At 2010-12-31 | 812,479 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 1996-08-16 to 2011-12-31 | 2,018,280 | USD | 5616 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -3,843,069 | USD | 365 |
| 1996-08-16 to 2011-12-31 | -29,318,381 | USD | 5616 |
| 2010-01-01 to 2010-12-31 | -2,372,954 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 653,345 | USD | |
| At 2010-12-31 | 373,274 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 2,294,274 | USD | |
| At 2010-12-31 | 1,581,109 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 23,276 | USD | |
| At 2010-12-31 | 23,276 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 3,843,069 | USD | 365 |
| 1996-08-16 to 2011-12-31 | 29,318,381 | USD | 5616 |
| 2010-01-01 to 2010-12-31 | 2,372,954 | USD | 365 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 111,832 | USD | 365 |
| 1996-08-16 to 2011-12-31 | 2,955,237 | USD | 5616 |
| 2010-01-01 to 2010-12-31 | 257,350 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 54,729,606 | shares | |
| At 2010-12-31 | 42,869,909 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 29,463,498 | USD | |
| At 2010-12-31 | 25,226,031 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 116,426 | USD | |
| At 2010-12-31 | 25,000 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -4,218,278 | USD | 365 |
| 1996-08-16 to 2011-12-31 | -30,018,213 | USD | 5616 |
| 2010-01-01 to 2010-12-31 | -2,615,046 | USD | 365 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 3,714,214 | USD | 365 |
| 1996-08-16 to 2011-12-31 | 26,261,003 | USD | 5616 |
| 2010-01-01 to 2010-12-31 | 2,109,555 | USD | 365 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 6,735 | USD | 365 |
| 1996-08-16 to 2011-12-31 | 91,842 | USD | 5616 |
| 2010-01-01 to 2010-12-31 | 6,049 | USD | 365 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -375,209 | USD | 365 |
| 1996-08-16 to 2011-12-31 | -699,832 | USD | 5616 |
| 2010-01-01 to 2010-12-31 | -242,092 | USD | 365 |
Inspect the source
- Entity
- Revolutions Medical CORP / CIK 0001041009
- Captured
- SEC response SHA-256
147399b6fb66b811b6d2c30d5167ca16121e9239b95a8a07106a6bdf6bbf37d5
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001041009.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))